Copy Link Print Information

Atorvastatin strontium

57 Cited Publications
Customer Review

Based on 57 publication(s) in Google Scholar

Strontium atorvastatin is a cholesterol-lowering drug with activity in ameliorating cardiovascular disease-related events. Strontium atorvastatin exerts its biological activity by inhibiting HMG-CoA reductase in liver tissue. Strontium atorvastatin is also used to suppress dyslipidemia.

For research use only. We do not sell to patients.

  • CAS No.: 1072903-92-4
  • Formula: C33H35FN2O5.1/2Sr
  • Molecular Weight:602.06
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Atorvastatin strontium Chemical Structure
    Atorvastatin strontium Chemical Structure
  • Experimental Validation Results for Atorvastatin strontium
  • Experimental Validation Results for Atorvastatin strontium
  • Experimental Validation Results for Atorvastatin strontium
  • Experimental Validation Results for Atorvastatin strontium
  • Experimental Validation Results for Atorvastatin strontium
  • Experimental Validation Results for Atorvastatin strontium
CAS No.: 1072903-92-4
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Atorvastatin strontium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Atorvastatin strontium

More
Customer Validation & Images
In Vivo Efficacy StudyWBCell Proliferation/Viability Assay
  • WB
  • In Vivo Efficacy Study
  • WB
  • WB
  • Cell Proliferation/Viability Assay
  • In Vivo Efficacy Study
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Atorvastatin strontium Chemical Structure
    Atorvastatin strontium Chemical Structure
    1/16
  • 1/16

    Atorvastatin strontium purchased from MedChemExpress. Usage Cited in: Environ Sci Technol Lett. 2025 Apr 8.

    Customer Validation
     The hCMEC-D3 cells were exposed to 0.01 μM 77PD-Q for 24 h in the presence or absence of 0.3 μM Atorvastatin (0.3 μM, 24 h).

  • 1/16

    Atorvastatin strontium purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2025 Oct:146:157128. [Abstract]

    Customer Validation
     ApoE-/- mice were administrated with high-fat-diet accompanied by MFEVLPs (5 or 50 μg/d, i.p) or Atorvastatin (10 mg/kg/day, i.g) for 12 weeks.

  • 1/16

    Atorvastatin strontium purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2023 Dec 25;8(1):457. [Abstract]

    Customer Validation
     EGFRvIII-high U87 cells were cocultured with EGFRvIII-CAR-T cells and treated with Atorvastatin (5 μM, 3 days) or Cytochalasin D (10 μg/mL, 1 day). Immunoblotting of magnetically separated cells showed that both drugs alleviated CAR molecule transfer (representative of three independent experiments).

  • 1/16

    Atorvastatin strontium purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2023 Jan 1:552:215976. [Abstract]

    Customer Validation
     Panc-1 and MIA PaCa-2 cells were treated with Atorvastatin (20 μM or 50 μM) for 24 h. FOXM1 and mutant p53 protein levels were measured in different treatment groups.

  • 1/16

    Atorvastatin strontium purchased from MedChemExpress. Usage Cited in: Oncogene. 2022 Dec;41(49):5266-5278. [Abstract]

    Customer Validation
     ATP assay. The combination of Atorvastatin (2.5, 5, 10, 20 μM; 48 h) and SR1078 synergistically inhibits CRC cell viability.

  • 1/16

    Atorvastatin strontium purchased from MedChemExpress. Usage Cited in: Mol Cell. 2021 Jul 1;81(13):2736-2751.e8. [Abstract]

    Customer Validation
     Tumor volumes of indicated patient-derived xenografts (PDXs) treated with Atorvastatin (40 mg/kg, i.p., every two days for 30 days).

  • Atorvastatin strontium